Year Established :
2016
Total Assets(USD) :
500,000 to 99,999,999
Total Number of Staff :
100-500
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Business Type :
Manufacturer
R&D Capacity :
OEM,ODM,Own Brand
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Range :
With a focus on pharmaceutical and small molecule drugs R&D, pharmaceutical intermediates, new bio-based molecules and materials, biopharmaceuticals, genetic engineering bacterial biosynthesis enzymes, CMO/CDMO custom chemicals and liquid crystal OLED materials.